Main > CRITICAL/INTENSIVE CARE MEDICINE > USA. E. Malignant Hyperthermia>

---

USA. E. Malignant Hyperthermia>'s subsections
(*) USA Approval Date: 2014. 08.06
>Treat.>Dantrolene Na for Inj. Susp
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2017. 10.17.
TradeMark
TradeMark Web-Site

USA. E. Malignant Hyperthermia>'s products
This section has no products